Participant flow

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer · Source last updated 2019-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Oxaliplatin + Leucovorin + 5-Fluorouracil

   id

   FG000

   title

   Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil

2. description

   Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab

   id

   FG001

   title

   Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         15

      2. group Id

         FG001

         num Subjects

         18

      type

      No follow-up data

   2. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         2

      type

      Patient not at risk for primary endpoint

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         1356

      2. group Id

         FG001

         num Subjects

         1354

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         1338

      2. group Id

         FG001

         num Subjects

         1334

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         18

      2. group Id

         FG001

         num Subjects

         20

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice